Natalia Elizalde, Ph.D., Business Development Director San Sebastian, Spain (Private) Virtual Presentation  VIVEbiotech is a contract development and manufacturing organization developing and GMP manufacturing lentiviral vectors with wide and robust experience in manufacturing vectors for rare/ultra rare diseases and for immune-cell therapy projects. VIVEbiotech works according to the regulations...

Mya Thu, Co-Founder and CEO San Diego, CA (Private) Virtual Presentation VisiCELL Medical, “GPS for cell therapy”, provides non-invasive, imaging-based cell tracking solutions to customers in the multi-billion dollar cell therapy industry. Our patent-pending solutions arm users with early and rapid clinical information for timely decision making on treatment...

Amy DuRoss, Co-Founder and CEO San Francisco, CA (Private) Virtual Presentation  Vineti creates the essential software solution to drive and scale personalized therapies, such as cell and gene therapies. Our leading Personalized Therapy Management® platform delivers simplicity, compliance, and patient safety to medicine’s most complex supply chain, providing the...

Jeffrey Hung, Ph.D., Chief Commercial Officer Rockville, MD (Private) Virtual Presentation Vigene Biosciences is an award-winning world leader in plasmid and viral vector development and manufacturing. Vigene features integrated plasmid and viral vector production and analytical service offerings from its 110,000 sq. ft. state-of-the-art facility with over 15 GMP...

Tim Lu, M.D., Ph.D., CEO San Francisco, CA (Private) Virtual Presentation Senti Biosciences’ mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that we believe may enable us to...

BG Rhee, Ph.D., President and CEO Seoul, Korea (KOSDAQ: 2908060) Virtual Presentation SCM Lifescience is developing allogeneic high purity clonal mesenchymal stem cells for immune related diseases. Three projects that are currently in the Phase II clinical stage deal with moderate to severe atopic dermatitis, chronic GvHD, and moderate...

Jenny Emanuel, CEO Bridgend, United Kingdom (AIM: RENE) Virtual Presentation ReNeuron is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop off-the-shelf stem cell treatments, without the need for immunosuppressive drugs. The company’s lead cell therapy candidate is in clinical development for the blindness-causing...

Cindy Atwell, Senior Vice President, Business Development Durham, NC (NASDAQ: DTIL) Virtual Presentation Precision BioSciences is a clinical-stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform designed with therapeutic safety, delivery, and...

Géraldine Guerin-Peyrou, Chief Marketing Officer Strasbourg, France (Private) Virtual Presentation  Polyplus-transfection applies its 20 years of expertise to the development of novel transfection solutions. Polyplus-transfection is the leading supplier of a key critical component for viral vector manufacturing for gene and cell therapy. We are proud to provide qualified...

Bobby Gaspar, M.D., Ph.D., CEO London, United Kingdom (NASDAQ: ORTX) Virtual Presentation Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by severe diseases through the development of innovative, potentially curative gene therapies. Our ex vivo autologous gene therapy approach harnesses the...

By using this website you agree to accept our Privacy Policy and Terms & Conditions